News | March 10, 2023
NATCO launches additional strengths for generic version of Revlimid in USA
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Natco Pharma has reported consolidated financial results for the period ended September 30, 2021
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
At present 18 per cent of the local pharmaceutical market is under government's price control
Lenalidomide is used to treat cancer and also some anaemia disorders
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
Subscribe To Our Newsletter & Stay Updated
